| 1 (26) | IBM Research | MUL |  |
| 2 (36) | F. Hoffmann-La Roche * | MUL | |
| 3 (37) | Novartis * | MUL | |
| 4 (43) | Merck * | MUL | |
| 5 (58) | Pfizer * | MUL | |
| 6 (74) | Biogen Idec | MUL | |
| 7 (92) | GlaxoSmithKline * | MUL | |
| 8 (110) | Abbott Laboratories * | MUL | |
| 9 (120) | Amgen | MUL | |
| 10 (134) | Johnson & Johnson * | MUL | |
| 11 (146) | Bristol-Myers Squibb Company | MUL | |
| 12 (150) | Nokia | MUL | |
| 13 (169) | Alcatel-Lucent | MUL | |
| 14 (183) | Bayer * | MUL | |
| 15 (205) | Yahoo Labs | MUL | |
| 16 (223) | AstraZeneca * | MUL | |
| 17 (242) | Philips Healthcare | MUL | |
| 18 (263) | Boehringer Ingelheim | MUL | |
| 19 (272) | Hewlett Packard | MUL | |
| 20 (292) | Takeda Pharmaceuticals International, Inc. | MUL | |
| 21 (293) | Eli Lilly * | MUL | |
| 22 (309) | Texas Instruments | MUL | |
| 23 (316) | Nestle | MUL | |
| 24 (332) | Baxter | MUL | |
| 25 (368) | Ericsson | MUL | |
| 26 (409) | Sanofi-Aventis * | MUL | |
| 27 (550) | Daiichi Sankyo Co., Ltd. | MUL | |
| 28 (577) | Synopsys, Inc. | MUL | |
| 29 (836) | Mentor Graphics, Inc. | MUL | |
| 30 (881) | Schlumberger | MUL | |
| 31 (944) | Shell | MUL | |
| 32 (1165) | BP plc | MUL | |
| 33 (1302) | ABB | MUL | |
| 34 (1477) | Statoil ASA | MUL | |
| 35 (1529) | General Motors Company | MUL | |
| 36 (2120) | TOTAL | MUL | |
| 37 (3524) | CH2M Hill | MUL | |
|
